Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

circulating tumor marker

(SER-kyoo-LAY-ting TOO-mer MAR-ker)
A substance, such as a protein or fragment of DNA, that is released into a person’s blood, urine, other body fluid, or stool by tumor cells or other cells of the body. Circulating tumor markers may be a sign of cancer or certain benign (noncancer) conditions. Measurements of circulating tumor marker levels in blood or other body fluid may be used along with results of other tests, such as biopsies and imaging, to help diagnose some types of cancer. Knowing the levels of circulating tumor markers may also help plan cancer treatment, make a likely prognosis, and find out how well treatment is working or if cancer has come back. Examples of circulating tumor markers include CA-125 (in ovarian cancer), calcitonin (in medullary thyroid cancer), EGFR mutations (in lung cancer), and beta-2-microglobulin (in multiple myeloma, chronic lymphocytic leukemia, and some lymphomas).
More Information
Search NCI's Dictionary of Cancer Terms